Cefepime Hydrochloride Injection — FDA Drug Shortage

To Be Discontinued — Fresenius Kabi USA, LLC

The FDA lists a drug shortage record for Cefepime Hydrochloride Injection (injection) from Fresenius Kabi USA, LLC with status To Be Discontinued. The shortage was first posted on Feb 10, 2026.

Shortage details

Status
To Be Discontinued
Company
Fresenius Kabi USA, LLC
Package NDC
63323-340-20
Dosage Form
Injection
Presentation
Cefepime Hydrochloride, Injection, 2 g (NDC 63323-340-20)
Initial Posting
Feb 10, 2026

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.